cas 19064-64-3|| where to buy 3,6-dichloro-4-methylpyridazine

製品名:3,6-dichloro-4-methylpyridazine

IUPAC Name:3,6-dichloro-4-methylpyridazine

包装単位	有効在庫	価格（USD）
CM102253-100g	in stock	ŗǙ
CM102253-500g	in stock	ƿĲŗ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

追記事項

Verification code*

refresh

: CAS番号:19064-64-3; 分子式:C5H4Cl2N2; 融点:-; SMILESコード:CC1=CC(Cl)=NN=C1Cl; 密度:

: カタログ番号:CM102253; 分子量:163; 沸点:272.1°C; MDL番号:MFCD00006465; 保管方法:Store at 2-8°C.

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Risdiplam; As the first approved small molecule splicing modifier drug, Risdiplam (Evrysdi) is granted approval by the European Commission to expand the EU marketing authorization. This extension now includes infants with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies from birth to below two months. Type 1 spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease and a leading genetic factor of infant mortality, that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam modifies SMN2 pre-messenger RNA splicing and increases levels of functional SMN protein in both the central nervous system and peripheral organs.